These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4837654)

  • 21. Coagulation and fibrinolytic activity in Behçet's disease.
    Hampton KK; Chamberlain MA; Menon DK; Davies JA
    Thromb Haemost; 1991 Sep; 66(3):292-4. PubMed ID: 1745999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Could be serum uric acid a risk factor for thrombosis and/or uveitis in Behcet's disease?
    Atıl A; Deniz A
    Vascular; 2018 Aug; 26(4):378-386. PubMed ID: 29360007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Is Behçet's disease associated with characteristic abnormalities of coagulation and fibrinolysis? Apropos of 70 case reports].
    Conard J; Horellou MH; Wechsler B; Fassin D; Bletry O; Godeau P; Samama M
    J Mal Vasc; 1988; 13(3):257-61. PubMed ID: 3171405
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Butyrate-Rich Diets Improve Redox Status and Fibrin Lysis in Behçet's Syndrome.
    Emmi G; Bettiol A; Niccolai E; Ramazzotti M; Amedei A; Pagliai G; Taddei N; Sofi F; Fiorillo C; Prisco D; Becatti M
    Circ Res; 2021 Jan; 128(2):278-280. PubMed ID: 33198585
    [No Abstract]   [Full Text] [Related]  

  • 25. Increased solubilization of immune complexes by the sera from patients with Behcet's disease.
    Tanaka K; Kajiyama K; Kameda S; Nishigouri S; Yamada I; Sawae Y
    Tohoku J Exp Med; 1983 Aug; 140(4):363-8. PubMed ID: 6636135
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Association of Behçet's disease and pelvispondylitis in a subject without HLA W 27 antigen].
    Laroche C; Cremer GA; Patri B; Remy JM; Letellier P
    Sem Hop; 1975 Oct; 51(42):2501-8. PubMed ID: 175493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies on the blood fibrinolytic enzyme system of patients with cutaneous vasculitis.
    Toki N; Yamura T
    Br J Dermatol; 1980 Jul; 103(1):41-50. PubMed ID: 6775670
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of the fibrinolytic system in Behçet's disease?
    Asbeck F; Meyer-Boernecke D; van de Loo J
    Haemostasis; 1977; 6(5):303-9. PubMed ID: 598751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haemostasis, thrombosis, and endothelium in Behçet's disease.
    Haznedaroğlu IC; Celik I; Büyükaşik Y; Koşar A; Kirazli S; Dündar SV
    Acta Haematol; 1998; 99(4):236-7. PubMed ID: 9644305
    [No Abstract]   [Full Text] [Related]  

  • 30. Current concepts of Behçet's disease.
    Collum LM; Mullaney J; Bowell R
    Trans Ophthalmol Soc U K (1962); 1981; 101 (Pt 4)():422-8. PubMed ID: 6964263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Laboratory findings in Behcet's disease].
    Biyâl F; Sezer N; Hâtemi H; Altay L
    Turk Tip Cemiy Mecm; 1969 Oct; 35(10):603-8. PubMed ID: 4190922
    [No Abstract]   [Full Text] [Related]  

  • 32. Serum prolactin levels in Behçet's disease. Is there a relationship between Behcet's disease and prolactin as in other autoimmune diseases?
    Avci A; Avci D
    Acta Dermatovenerol Croat; 2013; 21(1):52-3. PubMed ID: 23683488
    [No Abstract]   [Full Text] [Related]  

  • 33. Serum interleukin 18 and tumour necrosis factor-alpha levels are increased in Behcet's disease.
    Oztas MO; Onder M; Gurer MA; Bukan N; Sancak B
    Clin Exp Dermatol; 2005 Jan; 30(1):61-3. PubMed ID: 15663506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Do hemorheological alterations play any role in the development of thrombotic events in Behçet's disease?
    Vayá A; Ricart J; Todolí J; Micó L; Contreras T; Aznar J
    Clin Hemorheol Microcirc; 2004; 30(3-4):411-4. PubMed ID: 15258375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathological haemostasis and "prothrombotic state" in Behçet's disease.
    Kiraz S; Ertenli I; Oztürk MA; Haznedaroğlu IC; Celik I; Calgüneri M
    Thromb Res; 2002 Jan; 105(2):125-33. PubMed ID: 11958802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum leptin concentration is increased in patients with Behçet's syndrome and is correlated with disease activity.
    Evereklioglu C; Inalöz HS; Kirtak N; Doganay S; Bülbül M; Ozerol E; Er H; Ozbek E
    Br J Dermatol; 2002 Aug; 147(2):331-6. PubMed ID: 12174107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibodies to oral mucosa in patients with ocular Behcet's disease.
    Michelson JB; Chisari FV; Kansu T
    Ophthalmology; 1985 Sep; 92(9):1277-81. PubMed ID: 4058888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduced erythrocyte deformability in active and untreated Behçet's disease patients.
    Tatlican S; Duran FS; Eren C; Eskioglu F; Dikmenoglu N; Oktay B; Durmazlar SP; Canpolat F
    Int J Dermatol; 2010 Feb; 49(2):167-71. PubMed ID: 20465640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eicosanoids in the prethrombotic state of Behçet's disease.
    Haznedaroğlu IC; Dündar S; Kirazh S
    Thromb Res; 1995 Dec; 80(5):445-6. PubMed ID: 8588207
    [No Abstract]   [Full Text] [Related]  

  • 40. Serum leptin levels in patients with ocular and nonocular Behçet's disease.
    Yalçindağ FN; Kisa U; Batioğlu F; Yalçindağ A; Ozdemir O; Cağlayan O
    Mediators Inflamm; 2007; 2007():31986. PubMed ID: 17641728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.